Our merger with Aceragen is a key development in our goal to help patients with rare diseases get more from life.
Learn MoreDURHAM, N.C. and EXTON, Pa. , Aug. 04, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the “Company”)… Read more
DURHAM, N.C. and EXTON, Pa. , May 30, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the “Company”)… Read more
DURHAM, N.C. and EXTON, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (Nasdaq: ACGN) a… Read more